In a 21-center study, CHOC hopes to discover early treatment strategies for infantile spasms, a rare and dangerous type of epileptic seizure.
In the spotlight: Dr. John Crawford
Learn more about Dr. John Crawford, CHOC’s Medical Director of Neurology and Co-Medical Director of the CHOC Neuroscience Institute.
Neurologist to lead first-ever study of kids with Down syndrome to assess their likelihood of developing Alzheimer’s disease in adulthood
The study will examine biochemical markers in the blood of children with Down syndrome for a likelihood of them developing Alzheimer’s disease in adulthood.
Responsive neurostimulation (RNS) shows promise for treating young patients with epilepsy
CHOC sees success with Responsive neurostimulation (RSN), a promising new treatment to prevent seizures in kids with epilepsy.
Neurologist awarded patent for novel technology to treat victims of brain injury and stroke
The patent for light-emitting nanoparticles will significantly advance CHOC’s research to develop non-invasive treatments for brain injuries.
Enzyme replacement therapy slows progression of CLN2 Disease
CHOC is at the forefront to offer breakthrough enzyme replacement therapy to improve the quality of life for children with CLN2.
